SureNano Secures Up to $1.25 Million in Private Placement

SureNano Science Ltd. has announced plans for a private placement that could raise up to $1.25 million. The Vancouver-based company, trading under the ticker symbols CSE: SURE and OTCQB: SURNF, will offer up to 10 million units at a price of $0.125 per unit. Each unit will consist of one common share and one warrant, allowing investors to purchase an additional common share at a price of $0.35 for a period of 24 months following issuance.

The proposed private placement includes an acceleration clause for the warrants. Should the company’s shares trade at or above $0.50 on the Canadian Securities Exchange for ten consecutive trading days, SureNano may accelerate the expiry of the warrants, notifying holders that they will expire 30 days after the notice date.

In return for their assistance in introducing potential investors to the placement, finders will receive a commission of 6% in cash and warrants, with the latter exercisable at the same price of $0.35 for the same duration. The proceeds from this placement are earmarked for operating expenses, including legal and audit fees, and general working capital, which will help explore new markets for SureNano’s innovative surfactant.

Overview of SureNano’s Business Operations

SureNano specializes in the sale and distribution of its proprietary SureNanoTM surfactant, a food-grade compound designed to create stable and homogeneous nanoemulsions. This technology enhances product bioavailability, clarity, and taste. The company holds an exclusive license to distribute this surfactant in Canada and select U.S. states, specifically Oklahoma and Colorado.

The private placement is part of SureNano’s strategy to bolster its market presence and further develop its product line. By securing additional capital, the company aims to investigate complementary industries and expand its reach.

Charles MaLette, CEO, President, Director, and Secretary of SureNano, has expressed confidence in the company’s growth trajectory. The company emphasizes that all securities issued in the private placement will be subject to a four-month hold period, in accordance with regulatory requirements.

As the company moves forward with this funding initiative, it remains focused on leveraging its innovative products to capture a growing market demand in the surfactant industry.

Investors should note that this announcement may include forward-looking information as defined by Canadian securities legislation. While SureNano believes its projections are based on reasonable expectations, it does caution against undue reliance on such information, as future results may differ.

The Canadian Securities Exchange has not reviewed or accepted responsibility for the accuracy of this announcement. For further details or inquiries, interested parties may contact SureNano directly.